Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Androgen insensitivity syndrome pathophysiology

Introduction

Overview

Overview

Androgen insensitivity syndrome is due to hormone resistance which may be due to defective androgen receptor (AR) function by either abnormal androgen receptor (AR) binding, decreased receptor binding, or impaired androgen receptor (AR) binding. AIS is an X linked disorder. The development of androgen insensitivity syndrome is a result of genetic mutations of the androgen receptor (AR) gene located on the chromosome Xq11-12. Associated conditions include primary amenorrhea, infertility and dyspareunia.

Pathophysiology

Pathophysiology

Pathogenesis

By Jonathan.Marcus (Own work) [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0) or GFDL (http://www.gnu.org/copyleft/fdl.html)], via Wikimedia Commons
By Jonathan.Marcus (Own work) [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0) or GFDL (http://www.gnu.org/copyleft/fdl.html)], via Wikimedia Commons

Genetics

By U.S. National Library of Medicine; David-Sarah Hopwood (Originally from http://ghr.nlm.nih.gov/) [Public domain], via Wikimedia Commons
Associated Conditions

Associated Conditions

Gross Pathology

Gross Pathology

Microscopic Pathology

Microscopic Pathology

References

References

  1. ↑ Flier, Jeffrey S.; Underhill, Lisa H.; Griffin, James E. (1992). “Androgen Resistance β€” The Clinical and Molecular Spectrum”. New England Journal of Medicine. 326 (9): 611–618. doi:10.1056/NEJM199202273260906. ISSNΒ 0028-4793.
  2. ↑ Brown, Terry R.; Maes, Marc; Rothwell, Stephen W.; Migeon, Claude J. (1982). “Human Complete Androgen Insensitivity with Normal Dihydrotestosterone Receptor Binding Capacity in Cultured Genital Skin Fibroblasts: Evidence for a Qualitative Abnormality of the Receptor*”. The Journal of Clinical Endocrinology & Metabolism. 55 (1): 61–69. doi:10.1210/jcem-55-1-61. ISSNΒ 0021-972X.
  3. ↑ Griffin, James E. (1979). “Testicular Feminization Associated with a Thermolabile Androgen Receptor in Cultured Human Fibroblasts”. Journal of Clinical Investigation. 64 (6): 1624–1631. doi:10.1172/JCI109624. ISSNΒ 0021-9738.
  4. ↑ 4.0 4.1 4.2 4.3 4.4 4.5 Kota SK, Gayatri K, Kota SK, Jammula S (2013). “Genetic analysis of a family with complete androgen insensitivity syndrome”. Indian J Hum Genet. 19 (3): 355–7. doi:10.4103/0971-6866.120820. PMCΒ 3841565. PMIDΒ 24339553.
  5. ↑ Brinkmann AO, Faber PW, van Rooij HC, Kuiper GG, Ris C, Klaassen P, van der Korput JA, Voorhorst MM, van Laar JH, Mulder E (1989). “The human androgen receptor: domain structure, genomic organization and regulation of expression”. J. Steroid Biochem. 34 (1–6): 307–10. PMIDΒ 2626022.
  6. ↑ McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Wilson JD (1991). “Androgen resistance caused by mutations in the androgen receptor gene”. FASEB J. 5 (14): 2910–5. PMIDΒ 1752359.
  7. ↑ Evans BA, Hughes IA, Bevan CL, Patterson MN, Gregory JW (1997). “Phenotypic diversity in siblings with partial androgen insensitivity syndrome”. Arch. Dis. Child. 76 (6): 529–31. PMCΒ 1717223. PMIDΒ 9245853.
  8. ↑ Nichols JL, Bieber EJ, Gell JS (2009). “Case of sisters with complete androgen insensitivity syndrome and discordant MΓΌllerian remnants”. Fertil. Steril. 91 (3): 932.e15–8. doi:10.1016/j.fertnstert.2008.09.027. PMIDΒ 18930210.
  9. ↑ Ozdemir O, Sari ME, Akmut E, Selimova V, Unal T, Atalay CR (2014). “Complete androgen insensitivity syndrome with a large gonadal serous papillary cystadenofibroma”. J Hum Reprod Sci. 7 (2): 148–50. doi:10.4103/0974-1208.138875. PMCΒ 4150143. PMIDΒ 25191030.
  10. ↑ Hughes IA, Deeb A (2006). “Androgen resistance”. Best Pract. Res. Clin. Endocrinol. Metab. 20 (4): 577–98. doi:10.1016/j.beem.2006.11.003. PMIDΒ 17161333.
  11. ↑ Viner RM, Teoh Y, Williams DM, Patterson MN, Hughes IA (1997). “Androgen insensitivity syndrome: a survey of diagnostic procedures and management in the UK”. Arch. Dis. Child. 77 (4): 305–9. PMCΒ 1717340. PMIDΒ 9389232.
  12. ↑ 12.0 12.1 12.2 12.3 Akella RR (2017). “Mutational Analysis of Androgen Receptor Gene in Two Families with Androgen Insensitivity”. Indian J Endocrinol Metab. 21 (4): 520–523. doi:10.4103/ijem.IJEM_345_16. PMCΒ 5477437. PMIDΒ 28670533.
  13. ↑ Li L, Liu WM, Liu MX, Zheng SQ, Zhang JX, Che FY, Liu SG (2017). “A missense mutation in the androgen receptor gene causing androgen insensitivity syndrome in a Chinese family”. Asian J. Androl. 19 (2): 260–261. doi:10.4103/1008-682X.172647. PMCΒ 5312231. PMIDΒ 26806084.
  14. ↑ Brinkmann, Albert O. (2001). “Molecular basis of androgen insensitivity”. Molecular and Cellular Endocrinology. 179 (1–2): 105–109. doi:10.1016/S0303-7207(01)00466-X. ISSNΒ 0303-7207.
  15. ↑ Hughes IA, Werner R, Bunch T, Hiort O (2012). “Androgen insensitivity syndrome”. Semin Reprod Med. 30 (5): 432–42. doi:10.1055/s-0032-1324728. PMIDΒ 23044881.
  16. ↑ 16.0 16.1 Bhaskararao G, Himabindu Y, Nayak SR, Sriharibabu M (2014). “Laparoscopic gonedectomy in a case of complete androgen insensitivity syndrome”. J Hum Reprod Sci. 7 (3): 221–3. doi:10.4103/0974-1208.142498. PMCΒ 4229800. PMIDΒ 25395750.
  17. ↑ 17.0 17.1 17.2 17.3 17.4 17.5 17.6 Souhail R, Amine S, Nadia A, Tarik K, Khalid EK, Abdellatif K, Ahmed A (2016). “Complete androgen insensitivity syndrome or testicular feminization: review of literature based on a case report”. Pan Afr Med J. 25: 199. doi:10.11604/pamj.2016.25.199.10758. PMCΒ 5326263. PMIDΒ 28270903.
  18. ↑ 18.0 18.1 18.2 Lachiri B, Hakimi I, Boudhas A, Guelzim K, Kouach J, Oukabli M, Rahali DM, Dehayni M (2015). “[Complete androgen insensitivity syndrome: report of two cases and review of literature]”. Pan Afr Med J (in French). 20: 400. doi:10.11604/pamj.2015.20.400.6760. PMCΒ 4524922. PMIDΒ 26301004.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]